MEI Pharma Competitors and Similar CompaniesClear all
MEI Pharma's competitors and similar companies include ESSA Pharma, Sunesis Pharmaceuticals, Takeda and Puma Biotechnology.
 MEI Pharma MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. |  ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. |  Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | |
Founding Date | Founding Date 2000 | Founding Date 2009 | Founding Date 1987 | Founding Date 1781 | Founding Date 2010 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations South San Francisco, US HQ | Locations Los Angeles, US HQ | |
Employees | Employees 4025% increase | Employees 35 | Employees 42 | Employees 47,4554% decrease | Employees 27214% decrease |
Valuation ($) | Valuation ($) 21.1 m | Valuation ($) 240 m | Valuation ($) N/A | Valuation ($) 43.7 b | Valuation ($) 136.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $65.3m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $58.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit $170.2m (FY, 2025) |
Net income | Net income $17.8m (FY, 2024) | Net income ($28.5m) (FY, 2024) | Net income ($114.8m) (FY, 2021) | Net income ¥108.1b (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1.1m | Total funding raised $ 74.1m | Total funding raised $ 171.7m | Total funding raised $ 57.8m | Total funding raised $ 172m |
For sources of this data, please see the company profile
View Company Profiles
ESSA Pharma
HQ
Vancouver, CA
Employees
35
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
View companySunesis Pharmaceuticals
HQ
South San Francisco, US
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company